These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10861433)

  • 1. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.
    Goldstein NS; Vicini FA; Kestin LL; Thomas M
    Cancer; 2000 Jun; 88(11):2553-60. PubMed ID: 10861433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 2000 Aug; 24(8):1058-67. PubMed ID: 10935646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 1999 Nov; 23(11):1340-8. PubMed ID: 10555002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
    Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
    Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
    Neuschatz AC; DiPetrillo T; Steinhoff M; Safaii H; Yunes M; Landa M; Chung M; Cady B; Wazer DE
    Cancer; 2002 Apr; 94(7):1917-24. PubMed ID: 11932892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.
    Collins LC; Achacoso N; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP; Puligandla B; Alshak NS; Goldstein LC; Gown AM; Schnitt SJ; Habel LA
    Am J Surg Pathol; 2009 Dec; 33(12):1802-8. PubMed ID: 19950406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.
    Bruenderman EH; Bhutiani N; Mercer MK; McMasters KM; Sanders MAG; Ajkay NL
    J Surg Oncol; 2019 May; 119(6):694-699. PubMed ID: 30742316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
    Bijker N; Peterse JL; Duchateau L; Julien JP; Fentiman IS; Duval C; Di Palma S; Simony-Lafontaine J; de Mascarel I; van de Vijver MJ
    J Clin Oncol; 2001 Apr; 19(8):2263-71. PubMed ID: 11304780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast.
    Goldstein NS; Lacerna M; Vicini F
    Am J Clin Pathol; 1998 Sep; 110(3):357-67. PubMed ID: 9728611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.
    Vicini FA; Kestin LL; Goldstein NS; Baglan KL; Pettinga JE; Martinez AA
    J Surg Oncol; 2001 Apr; 76(4):245-54. PubMed ID: 11320515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
    Chagpar A; Yen T; Sahin A; Hunt KK; Whitman GJ; Ames FC; Ross MI; Meric-Bernstam F; Babiera GV; Singletary SE; Kuerer HM
    Am J Surg; 2003 Oct; 186(4):371-7. PubMed ID: 14553853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.
    Vicini FA; Kestin LL; Goldstein NS; Chen PY; Pettinga J; Frazier RC; Martinez AA
    J Clin Oncol; 2000 Jan; 18(2):296-306. PubMed ID: 10637243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy.
    Vicini FA; Goldstein NS; Kestin LL
    Ann Oncol; 1999 Aug; 10(8):883-90. PubMed ID: 10509147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.
    Asioli S; Morandi L; Cavatorta C; Cucchi MC; Foschini MP
    Eur J Surg Oncol; 2016 Dec; 42(12):1806-1813. PubMed ID: 27546014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ.
    Chan KC; Knox WF; Sinha G; Gandhi A; Barr L; Baildam AD; Bundred NJ
    Cancer; 2001 Jan; 91(1):9-16. PubMed ID: 11148554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
    Song HM; Styblo TM; Carlson GW; Losken A
    Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.